CIK: 0001807489 · Show all filings
Period: Q4 2023 (← Previous) (Next →)
Filing Date: Feb 12, 2024
Total Value ($000): $120,706 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| WVE | WAVE LIFE SCIENCES LTD | 7,373,413 | $37,236 | 30.8% | $3.40 | +57.3% | SHS | Y95308105 |
| IVVD | INVIVYD INC | 9,248,250 | $36,438 | 30.2% | $17.64 | -89.3% | COM | 00534A102 |
| RCKT | ROCKET PHARMACEUTICALS INC | 523,280 | $15,683 | 13.0% | $23.75 | -7.1% | COM | 77313F106 |
| SLN | SILENCE THERAPEUTICS PLC | 363,800 | $6,319 | 5.2% | $9.41 | — | ADS | 82686Q101 |
| CRIS | CURIS INC | 421,951 | $5,380 | 4.5% | $12.87 | -38.0% | COM | 231269309 |
| — | SPRINGWORKS THERAPEUTICS INC | 142,800 | $5,212 | 4.3% | $25.89 | — | COM | 85205L107 |
| BBIO | BRIDGEBIO PHARMA INC | 121,200 | $4,893 | 4.1% | $39.38 | -23.7% | COM | 10806X102 |
| PRQR | PROQR THRAPEUTICS N V | 1,910,600 | $3,783 | 3.1% | $2.38 | -35.4% | SHS EURO | N71542109 |
| TGTX | TG THERAPEUTICS INC | 216,600 | $3,700 | 3.1% | $15.49 | -25.0% | COM | 88322Q108 |
| ARWR | ARROWHEAD PHARMACEUTICALS IN | 67,400 | $2,062 | 1.7% | $33.13 | -19.8% | COM | 04280A100 |